Literature DB >> 6699074

The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.

E B Bröcker, G Kolde, D Steinhausen, A Peters, E Macher.   

Abstract

The mononuclear cell infiltrate of 90 superficial spreading melanomas (SSM) of less than or equal to 1.5 mm thickness was analyzed at different locations around and within the tumors. All patients had been followed for at least 5 years, and 20 (22%) had developed metastases. A correlation between the overall inflammatory response in the histologic sections and the prognosis was not observed, nor could a significant distinction be made between metastasizing and nonmetastasizing melanomas when the mononuclear cell infiltrate was analyzed at different locations. A significant clustering of metastasizing tumors was, however, observed in the subgroup with a relatively strong infiltrate within the tumor compared with the overall infiltrate. From this observation, a semiquantitative description of the pattern of the infiltrate was established. It provides an additional parameter for prognostication in flat SSMs and it raises new questions about the role of the local host-tumor interaction.

Entities:  

Mesh:

Year:  1984        PMID: 6699074     DOI: 10.1007/bf00395490

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  [Prognosis in primary malignant melanoma based on histological assessment (a comparative study between two groups with different length of survival)].

Authors:  E M Kokoschka; G Niebauer
Journal:  Wien Klin Wochenschr       Date:  1976-11-12       Impact factor: 1.704

2.  Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.

Authors:  M G Hansen; A B McCarten
Journal:  Am J Surg       Date:  1974-10       Impact factor: 2.565

3.  [Studies on the prognostic significance of the "stroma reactivity" to malignant melanoma. II. Inflammatory infiltration and prognosis].

Authors:  F Weidner; O P Hornstein
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973-03-20

4.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

5.  Independent induction of plasminogen activator and interferon in murine macrophages.

Authors:  C Neumann; C Sorg
Journal:  J Reticuloendothel Soc       Date:  1981-08

Review 6.  Prostaglandins and the immune response to cancer (review).

Authors:  J Ceuppens; J Goodwin
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

7.  Immunoproliferation and cancer: a common macrophage-derived promoter substance.

Authors:  S E Salmon; A W Hamburger
Journal:  Lancet       Date:  1978-06-17       Impact factor: 79.321

8.  Prognostic index in malignant melanoma.

Authors:  C Schmoeckel; O Braun-Falco
Journal:  Arch Dermatol       Date:  1978-06

9.  Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma.

Authors:  W Stenzinger; J Brüggen; E Macher; C Sorg
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

10.  In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.

Authors:  S Poppema; E B Bröcker; L de Leij; D Terbrack; T Visscher; A Ter Haar; E Macher; T H Thé; C Sorg
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

View more
  6 in total

Review 1.  Relevance of the T cell receptor for immunotherapy of cancer.

Authors:  E Weidmann; M Trucco; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

2.  Association of macrophages detected with monoclonal antibody 25 F 9 with progression and pathobiological classification of gastric carcinoma.

Authors:  G Heidl; P Davaris; G Zwadlo; M S Jagoda; S Düchting; E Bierhoff; T Grüter; V Krieg; C Sorg
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Oligoclonality of CD8+ T cells in breast cancer patients.

Authors:  K Ito; J Fetten; H Khalili; S Hajdu; E Busch; R Pergolizzi; V Vinciguerra; M D Chang
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

4.  HLA-DR antigen expression on melanoma metastases and the course of the disease.

Authors:  M Munzarová; D Zemanová; A Rejthar; Z Mechl; V Kolcová
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.

Authors:  G Mantovani; A Macciò; R Versace; M Pisano; P Lai; S Esu; M Ghiani; D Dessì; E Turnu; M C Santona
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

6.  The analysis of mononuclear cell infiltrations in colorectal adenocarcinoma.

Authors:  B Koch; J Giedl; P Hermanek; J R Kalden
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.